Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-16-016105
Filing Date
2016-04-29
Accepted
2016-04-29 17:07:31
Documents
26

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1727822
2 g16439g08h09.jpg GRAPHIC 122012
3 g16439g10t30.jpg GRAPHIC 66088
4 g16439g11d65.jpg GRAPHIC 50539
5 g16439g15e00.jpg GRAPHIC 86832
6 g16439g17u43.jpg GRAPHIC 62088
7 g16439g21g44.jpg GRAPHIC 90970
8 g16439g27c23.jpg GRAPHIC 32434
9 g16439g31v36.jpg GRAPHIC 47429
10 g16439g39g56.jpg GRAPHIC 95695
11 g16439g47g88.jpg GRAPHIC 68962
12 g16439g50q80.jpg GRAPHIC 90619
13 g16439g55i06.jpg GRAPHIC 129181
14 g16439g56h33.jpg GRAPHIC 47458
15 g16439g57t30.jpg GRAPHIC 71056
16 g16439g59n65.jpg GRAPHIC 72575
17 g16439g62k44.jpg GRAPHIC 61201
18 g16439g64u74.jpg GRAPHIC 54762
19 g16439g80t23.jpg GRAPHIC 35565
20 g16439g81p33.jpg GRAPHIC 53597
21 g16439g82l25.jpg GRAPHIC 93015
22 g16439g82t66.jpg GRAPHIC 53429
23 g16439g83h98.jpg GRAPHIC 85770
24 g16439g87q91.jpg GRAPHIC 89070
25 g16439g90m83.jpg GRAPHIC 61989
26 g16439g94k94.jpg GRAPHIC 23268
  Complete submission text file 0000950123-16-016105.txt   4135023
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 693 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01130 | Film No.: 161608070
SIC: 2834 Pharmaceutical Preparations